Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis

Molecular and Cellular Biology

Volumn 23, Issue 16, 2003, Pages 5726-5737

  Kawasaki, Koh ^a   Smith Jr , Robert S ^b   Hsieh, Chung Ming ^a   Sun, Jianxin ^a   Chao, Julie ^b   Liao, James K ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; ADENOVIRUS VECTOR; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; QUINOXALINE DERIVATIVE; S NITROSOGLUTATHIONE; WORTMANNIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CATTLE; CONTROLLED STUDY; DNA VECTOR; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIMB ISCHEMIA; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CAPILLARIES; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GENE TRANSFER TECHNIQUES; HUMANS; ISCHEMIA; LASER-DOPPLER FLOWMETRY; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROSO COMPOUNDS; OXADIAZOLES; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; QUINOXALINES; RATS; RECOMBINANT PROTEINS; S-NITROSOGLUTATHIONE; TIME FACTORS;

ADENOVIRIDAE; ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0041631006     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.16.5726-5737.2003     Document Type: Article

References (42)

1. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541-6551.
2. Babaei, S., and D. J. Stewart. 2002. Overexpression of endothelial NO synthase induces angiogenesis in a coculture model. Cardiovasc. Res. 55:190-200.
3. Bogdan, C. 2001. Nitric oxide and the regulation of gene expression. Trends Cell Biol. 11:66-75.
4. Broillet, M. C. 1999. S-nitrosylation of proteins. Cell. Mol. Life Sci. 55:1036-1042.
5. Buga, G. M., J. M. Griscavage, N. E. Rogers, and L. J. Ignarro. 1993. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 73:808-812.
6. Carmeliet, P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:389-395.
7. Cuevas, B. D., Y. Lu, M. Mao, J. Zhang, R. LaPushin, K. Siminovitch, and G. B. Mills. 2001. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276:27455-27461.
8. Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905-2927.
9. Denninger, J. W., and M. A. Marletta. 1999. Guanylate cyclase and the -NO/cGMP signaling pathway. Biochim. Biophys. Acta 1411:334-350.
10. Dimmeler, S., E. Dernbach, and A. M. Zeiher. 2000. Phosphorylation of the endothelial nitric oxide synthase at Ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 477:258-262.
11. Dimmeler, S., I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A. M. Zeiher. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605.
12. Dimmeler, S., J. Haendeler, M. Nehls, and A. M. Zeiher. 1997. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185:601-607.
13. Dimmeler, S., and A. M. Zeiher. 1999. Nitric oxide-an endothelial cell survival factor. Cell Death Differ. 6:964-968.
14. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
15. Fukumura, D., T. Gohongi, A. Kadambi, Y. Izumi, J. Ang, C. O. Yun, D. G. Buerk, P. L. Huang, and R. K. Jain. 2001. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. USA 98:2604-2609.
16. Fulton, D., J. P. Gratton, T. J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T. F. Franke, A. Papapetropoulos, and W. C. Sessa. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601.
17. Gooch, K. J., C. A. Dangler, and J. A. Frangos. 1997. Exogenous, basal, and flow-induced nitric oxide production and endothelial cell proliferation. J. Cell Physiol. 171:252-258.
18. Griscavage, J. M., A. J. Hobbs, and L. J. Ignarro. 1995. Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. Adv. Pharmacol. 34:215-234.
19. Janssens, S. P., A. Shimouchi, T. Quertermous, D. B. Bloch, and K. D. Bloch. 1992. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267:14519-14522.
20. Lau, Y. T., and W. C. Ma. 1996. Nitric oxide inhibits migration of cultured endothelial cells. Biochem. Biophys. Res. Commun. 221:670-674.
21. Liao, J. K., W. S. Shin, W. Y. Lee, and S. L. Clark. 1995. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270:319-324.
22. Marshall, H. E., and J. S. Stamler. 2001. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40:1688-1693.
23. Morales-Ruiz, M., D. Fulton, G. Sowa, L. R. Languino, Y. Fujio, K. Walsh, and W. C. Sessa. 2000. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ. Res. 86:892-896.
24. Morales-Ruiz, M., M. J. Lee, S. Zollner, J. P. Gratton, R. Scotland, I. Shiojima, K. Walsh, T. Hla, and W. C. Sessa. 2001. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J. Biol. Chem. 276:19672-19677.
25. Murohara, T., T. Asahara, M. Silver, C. Bauters, H. Masuda, C. Kalka, M. Kearney, D. Chen, J. F. Symes, M. C. Fishman, P. L. Huang, and J. M. Isner. 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Investig. 101:2567-2578.
26. Murohara, T., B. Witzenbichler, I. Spyridopoulos, T. Asahara, B. Ding, A. Sullivan, D. W. Losordo, and J. M. Isner. 1999. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 19:1156-1161.
27. Peng, H. B., M. Spiecker, and J. K. Liao. 1998. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J. Immunol. 161:1970-1976.
28. Purdie, K. J., G. S. Whitley, A. P. Johnstone, and J. E. Cartwright. 2002. Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardiovasc. Res. 54:659-668.
29. Ravichandran, L. V., R. A. John, and A. Rengasamy. 1995. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am. J. Physiol. 268:H2216-H2223.
30. Rikitake, Y., K. Hirata, S. Kawashima, M. Ozaki, T. Takahashi, W. Ogawa, N. Inoue, and M. Yokoyama. 2002. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 22:108-114.
31. Simoncini, T., A. Hafezi-Moghadam, D. P. Brazil, K. Ley, W. W. Chin, and J. K. Liao. 2000. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541.
32. Smith, R. S., Jr., K. F. Lin, J. Agata, L. Chao, and J. Chao. 2002. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hind limb ischemia. Arterioscler. Thromb. Vasc. Biol. 22:1279-1285.
33. Spiecker, M., H. B. Peng, and J. K. Liao. 1997. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J. Biol. Chem. 272:30969-30974.
34. Stuehr, D. J. 1999. Mammalian nitric oxide synthases. Biochim. Biophys. Acta 1411:217-230.
35. Suhara, T., T. Mano, B. E. Oliveira, and K. Walsh. 2001. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ. Res. 89:13-19.
36. Tamarat, R., J. S. Silvestre, N. Kubis, J. Benessiano, M. Duriez, M. deGasparo, D. Henrion, and B. I. Levy. 2002. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hind limb. Hypertension 39:830-835.
37. Thomsen, L. L., and D. W. Miles. 1998. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev. 17:107-118.
38. Toker, A., and A. C. Newton. 2000. Cellular signaling: pivoting around PDK-1. Cell 103:185-188.
39. Urbich, C., A. Reissner, E. Chavakis, E. Dernbach, J. Haendeler, I. Fleming, A. M. Zeiher, M. Kaszkin, and S. Dimmeler. 2002. Dephosphorylation of endothelial nitric oxide synthase contributes to the antiangiogenic effects of endostatin. FASEB J. 16:706-708.
40. Yamasaki, K., H. D. Edington, C. McClosky, E. Tzeng, A. Lizonova, I. Kovesdi, D. L. Steed, and T. R. Billiar. 1998. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Investig. 101:967-971.
41. Ziche, M., L. Morbidelli, E. Masini, S. Amerini, H. J. Granger, C. A. Maggi, P. Geppetti, and F. Ledda. 1994. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Investig. 94:2036-2044.
42. Ziche, M., A. Parenti, F. Ledda, P. Dell'Era, H. J. Granger, C. A. Maggi, and M. Presta. 1997. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ. Res. 80:845-852.